Preclinical studies in a mouse model of metastatic pancreatic adenocarcinoma demonstrated that CAR-T cells targeting MSLN can induce tumor cytotoxicity and eradicate lung metastases [48, 49]. This evidence concerns the gene MSLN and pancreatic adenocarcinoma.